Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Insmed (INSM) EBT (2016 - 2026)

Insmed's EBT history spans 17 years, with the latest figure at -$162.1 million for Q1 2026.

  • Quarterly EBT rose 36.6% to -$162.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$1.2 billion through Mar 2026, down 16.74% year-over-year, with the annual reading at -$1.3 billion for FY2025, 39.74% down from the prior year.
  • EBT came in at -$162.1 million for Q1 2026, up from -$326.9 million in the prior quarter.
  • In the past five years, EBT ranged from a high of -$94.2 million in Q1 2022 to a low of -$368.7 million in Q3 2025.
  • The 5-year median for EBT is -$185.1 million (2023), against an average of -$210.1 million.
  • Year-over-year, EBT plummeted 156.75% in 2023 and then surged 36.6% in 2026.
  • Insmed's EBT stood at -$160.0 million in 2022, then dropped by 15.67% to -$185.1 million in 2023, then decreased by 26.6% to -$234.3 million in 2024, then plummeted by 39.55% to -$326.9 million in 2025, then soared by 50.42% to -$162.1 million in 2026.
  • Per Business Quant, the three most recent readings for INSM's EBT are -$162.1 million (Q1 2026), -$326.9 million (Q4 2025), and -$368.7 million (Q3 2025).